Pyruvate kinase deficiency anaemia

Also known as: Pyruvate Kinase Deficiency Anemia / Anemia due to pyruvate kinase deficiency / HNSHA due to pyruvate kinase deficiency (disorder)

Drug	Drug Name	Drug Description
DB16236	Mitapivat	A pyruvate kinase activator used to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Drug	Drug Name	Target	Type
DB16236	Mitapivat	Cytochrome P450 3A4	enzyme
DB16236	Mitapivat	Cytochrome P450 2B6	enzyme
DB16236	Mitapivat	Cytochrome P450 2C8	enzyme
DB16236	Mitapivat	Cytochrome P450 2C9	enzyme
DB16236	Mitapivat	Cytochrome P450 2C19	enzyme
DB16236	Mitapivat	UDP-glucuronosyltransferase 1-1	enzyme
DB16236	Mitapivat	P-glycoprotein 1	transporter
DB16236	Mitapivat	Cytochrome P450 1A2	enzyme
DB16236	Mitapivat	Pyruvate kinase PKLR	target
DB16236	Mitapivat	Cytochrome P450 19A1	target

Drug	Drug Name	Phase	Status	Count